VUmc Stichting — Clinical Trial Site

31 Registered trials

9 Currently recruiting

Organisation

VUmc Stichting

Location

Amsterdam, Netherlands

Identifier

ORG-100021154

Address

De Boelelaan 1117, 1081 HV, Netherlands

Departments

#8003: Pulmonology
Anesthesiolog
Cardiology
Clinical Endocrinology and Internal medicine
Department of Hematology
Department of Pulmonary Medicine
Department of Pulmonology
Endocrinology
Gastroenterology and hepatology
Hematology
k.sigaloff
Longziekten
Medical Oncology
Neurologie
Neurology
Pulmonary department
Pulmonary Disease
Pulmonary diseases
Pulmonary Medicine
Rheumatology and Clinical Immunology
Urology

Clinical trials at this site (31)

Search interface

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Non-cystic Fibrosis Bronchiectasis 4
A Long-term Follow-up Study of Sotatercept for PAH Treatment Recruiting

2023-509138-21-00 Pulmonary Arterial Hypertension (PAH) 5 2021-08-26
Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial Recruiting

2024-516936-93-02 chemotherapy-induced peripheral neuropathy, chronic neu 4 2025-10-28
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer Recruiting

2024-515884-69-00 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 5 2025-07-16
Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan. Recruiting

2024-514489-38-01 giant cell arteritis 4 2024-11-26
A Phase I/II Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid Tumors Recruiting

2023-504139-42-00 Advanced or metastatic solid tumors 7 2024-09-06
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX versus mFOLFIRINOX Alone in Patients wit… Recruiting

2022-502404-73-00 Pancreatic ductal adenocarcinoma 4 2024-06-03
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f… Recruiting

2024-510892-40-00 Acute myocardial infarction complicated by cardiogenic 6 2024-02-29
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple M… Recruiting

2023-506247-42-00 Relapsed/Refractory Multiple Myeloma 3 2022-08-17
The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: a randomized multi-center study in resectable HER2… Recruiting

2024-513797-22-00 HER2 positive esophageal adenocarcinoma 5 2022-03-09
A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension… Ended

2024-513991-16-00 Pulmonary Hypertension Associated with Interstitial Lun 4 2025-01-17
Personalized extended interval dosing of natalizumab in relapsing remitting multiple sclerosis (NEXT-MS) Ended

2024-513105-31-00 Multiple Sclerosis 6 2024-07-30
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TR… Ended

2023-506082-60-00 Chronic Kidney Disease 4 2023-02-28
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor Long-term Safety and Efficacy in Subjects Without F508del Ended

2024-515637-14-00 Cystic Fibrosis 5 2022-11-08
A study to investigate the efficacy and safety of trastuzumab deruxtecan as the first treatment option for locally advanced/metastatic Non-S… Ended

2023-503674-20-00 Unresectable, locally advanced, or metastatic Non-Small 5 2021-12-17
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17
An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in patients with pulmonary arterial hypertens… Ended

2023-509305-68-00 Pulmonary arterial hypertension (PAH) 5 2019-05-16
A Phase 3 study to see the benefit and safety of Luspatercept in comparison with Epoetin Alfa to treat anaemia due to very low, low or inter… Ended

2022-501485-22-00 Myelodysplastic syndrome (MDS) 5 2018-12-18
A study to decide what is the highest dose of CC-220 to take alone and with other standard of care treatments to assess the side effects, ef… Ended

2024-510799-19-00 Multiple Myeloma 9 2016-08-09
An international study to evaluate the safety and effectiveness of enzalutamide plus leuprolide, enzalutamide alone, and leuprolide alone in… Ended

2024-513521-23-00 Prostate Cancer 5 2015-08-19
A research study looking at a new treatment for patients with advanced cancer, to investigate different doses of the experimental study drug… Halted

2024-514588-24-00 Acute Myeloid Leukaemia (AML) 7 2021-09-27
A study of efficacy and safety of various treatments in participants with idiopathic pulmonary fibrosis (IPF) Ended

2023-508729-28-00 Idiopathic pulmonary fibrosis 4 2023-04-25
Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosis Ended

2024-513099-17-00 Internuclear ophthalmoparesis 5 2022-08-30
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients. Ended

2023-509139-16-00 Therapeutic confirmatory (phase III) 5 2022-05-13